Cargando…

Hypofractionated carbon‐ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study

This phase II study's aim was to confirm the efficacy and safety of hypofractionated carbon‐ion radiotherapy in patients with stage I peripheral nonsmall cell lung cancer (NSCLC). The study encompassed 37 patients with histologically proven peripheral stage I NSCLC in the period June 2010‐March...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saitoh, Jun‐ichi, Shirai, Katsuyuki, Mizukami, Tatsuji, Abe, Takanori, Ebara, Takeshi, Ohno, Tatsuya, Minato, Koichi, Saito, Ryusei, Yamada, Masanobu, Nakano, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825999/ https://www.ncbi.nlm.nih.gov/pubmed/31532584 http://dx.doi.org/10.1002/cam4.2561

Ejemplares similares

Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
por: Kawamura, Hidemasa, et al.
Publicado: (2020)

Carbon-ion Radiotherapy for Isolated Lymph Node Metastasis After Surgery or Radiotherapy for Lung Cancer
por: Shirai, Katsuyuki, et al.
Publicado: (2019)

Efficacy and Safety of Carbon-Ion Radiotherapy for Stage I Non-Small Cell Lung Cancer with Coexisting Interstitial Lung Disease
por: Okano, Naoko, et al.
Publicado: (2021)

Prospective Study of Isolated Recurrent Tumor Re-irradiation With Carbon-Ion Beams
por: Shirai, Katsuyuki, et al.
Publicado: (2019)

A multi‐institutional retrospective study of carbon‐ion radiotherapy for non‐squamous cell malignant tumors of the nasopharynx: Subanalysis of Japan Carbon‐Ion Radiation Oncology Study Group study 1402 HN
por: Abe, Takanori, et al.
Publicado: (2018)

Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers
por: Shirai, Katsuyuki, et al.
Publicado: (2012)

Stereotactic body radiotherapy for adenoid cystic carcinoma metastatic to the lung: a case report
por: Kobayashi, Daijiro, et al.
Publicado: (2021)

Comparison of Oncologic Outcomes between Carbon Ion Radiotherapy and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
por: Miyasaka, Yuhei, et al.
Publicado: (2021)

Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma
por: Abe, Takanori, et al.
Publicado: (2015)

Prospective Observational Study of High-Dose Carbon-Ion Radiotherapy for Pelvic Recurrence of Rectal Cancer (GUNMA 0801)
por: Shiba, Shintaro, et al.
Publicado: (2019)

Carbon Ion Radiotherapy at the Gunma University Heavy Ion Medical Center: New Facility Set-up
por: Ohno, Tatsuya, et al.
Publicado: (2011)

Carbon‐ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: Prospective observational study
por: Takayasu, Yukihiro, et al.
Publicado: (2019)

Oral mucosal melanoma treated with carbon ion radiotherapy: a case report
por: Musha, Atsushi, et al.
Publicado: (2016)

Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer—A pilot study
por: Shirai, Katsuyuki, et al.
Publicado: (2017)

Translational Research to Improve the Efficacy of Carbon Ion Radiotherapy: Experience of Gunma University
por: Oike, Takahiro, et al.
Publicado: (2016)

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT‐0701 MAPS phase 3 trial
por: Maille, Elodie, et al.
Publicado: (2022)

Dosimetric comparison of carbon ion and X-ray radiotherapy for Stage IIIA non–small cell lung cancer
por: Kubo, Nobuteru, et al.
Publicado: (2016)

Five-year outcomes in carbon-ion radiotherapy for postoperative pelvic recurrence of rectal cancer: A prospective clinical trial (GUNMA 0801)
por: Shiba, Shintaro, et al.
Publicado: (2023)

Prediction of Acute Radiation Mucositis using an Oral Mucosal Dose Surface Model in Carbon Ion Radiotherapy for Head and Neck Tumors
por: Musha, Atsushi, et al.
Publicado: (2015)

Pathogen Profiles in Outpatients with Non-COVID-19 during the 7th Prevalent Period of COVID-19 in Gunma, Japan
por: Kimura, Hirokazu, et al.
Publicado: (2023)

Implementation and utilization of hypofractionation for breast cancer
por: Gilbo, Philip, et al.
Publicado: (2018)

Retrospective survey of sport climbing injuries and self-care in the Gunma prefecture
por: Asakawa, Daichi, et al.
Publicado: (2019)

Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K/Akt pathway
por: Wang, Yingying, et al.
Publicado: (2021)

Disparate outcomes in nonsmall cell lung cancer by immigration status
por: Chau, Brittney, et al.
Publicado: (2021)

Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy
por: Shrestha, Suman, et al.
Publicado: (2019)

Prospective observational study of carbon‐ion radiotherapy for non‐squamous cell carcinoma of the head and neck
por: Shirai, Katsuyuki, et al.
Publicado: (2017)

Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer
por: Saitoh, Jun-ichi, et al.
Publicado: (2017)

The Significance of Erythrocyte Sedimentation Rate as a Prognostic Factor for Patients with Prostate Cancer: Gunma Urological Oncology Study Group Investigation
por: Imai, Kyoichi, et al.
Publicado: (1990)

Long-term outcome of hypofractionated intensity-modulated radiotherapy using TomoTherapy for localized prostate cancer: A retrospective study
por: Takakusagi, Yosuke, et al.
Publicado: (2019)

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
por: Tfayli, Arafat, et al.
Publicado: (2020)

Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association
por: Mehta, Anurag, et al.
Publicado: (2019)

Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer—A Single Institution Experience With Long-Term Follow-Up
por: Karasawa, Katsuyuki, et al.
Publicado: (2018)

A retrospective multicenter study of carbon‐ion radiotherapy for external auditory canal and middle ear carcinomas
por: Hayashi, Kazuhiko, et al.
Publicado: (2018)

Multicenter study of carbon‐ion radiation therapy for nonsquamous cell carcinomas of the oral cavity
por: Ikawa, Hiroaki, et al.
Publicado: (2019)

Image Fusion for Radiosurgery, Neurosurgery and Hypofractionated Radiotherapy
por: Inoue, Hiroshi K, et al.
Publicado: (2015)

Assessment of associations between clinical and immune microenvironmental factors and tumor mutation burden in resected nonsmall cell lung cancer by applying machine learning to whole‐slide images
por: Ono, Akira, et al.
Publicado: (2020)

Quantitative medical cost-effectiveness analysis of molecular-targeting cancer drugs in Japan
por: Ebara, Takeshi, et al.
Publicado: (2013)

Polymyositis and fatal interstitial pneumonia following pelvic irradiation that led to unexpectedly severe adverse effects: a case report
por: Oike, Takahiro, et al.
Publicado: (2015)

Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma
por: Shiba, Shintaro, et al.
Publicado: (2020)

Multi‐institutional retrospective study of mucoepidermoid carcinoma treated with carbon‐ion radiotherapy
por: Shirai, Katsuyuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ml64e7enhn5ao80sq60a4q29vh